We are pleased to announce that William Schiemann, PhD has accepted the role of Director of the Case Comprehensive Cancer Center's 365betÌåÓýÔÚÏßÊÀ½ç±hymic Animal and Preclinical Therapeutics Shared Resource. Schiemann joins co-Director Daniel Lindner, MD, PhD in leading the two-location facility at Case Western Reserve University and Cleveland Clinic Taussig Cancer Institute.
Schiemann is the Goodman-Blum Professor in Cancer Research and member of the Case CCC's Molecular Oncology Program. The goal of the 365betÌåÓýÔÚÏßÊÀ½ç±hymic Animal and Preclinical Therapeutic Shared Resource is to help in the evaluation of new pharmacologic agents by providing data on tumor growth, metastasis, angiogenesis and gene expression.